Piper Sandler Reiterates Overweight on Nutanix, Lowers Price Target to $60

Benzinga Newsdesk www.benzinga.com Negative 92.7%

Neg 92.7% Neu 0% Pos 0%

Piper Sandler analyst James Fish reiterates Nutanix (NASDAQ:NTNX) with a Overweight and lowers the price target from $63 to $60.